Skip to main content

Advertisement

Log in

Evaluation of pattern electroretinogram in retinal vein occlusion treated with intravitreal triamcinolone acetonide

  • Original Research Article
  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Purpose

To evaluate pattern electroretinogram (pattern ERG) and anatomical changes in optical coherence tomography (OCT) in acute retinal vein occlusion with macular oedema after intravitreal triamcinolone acetonide (IVTA) injection.

Methods

In this prospective interventional study, 20 patients with acute retinal vein occlusion (branch and central) of less than 1 month duration were evaluated for pattern ERG, best-corrected visual acuity (BCVA), central macular thickness on OCT, and contrast sensitivity (CS) before and 1, 6 and 12 weeks after 1 mg IVTA injection.

Results

The amplitude of P50 wave (pattern ERG) improved from 3.01 ± 1.22 to 3.56 ± 1.29 µv, mean logMAR BCVA improved from 1.10 ± 0.60 to 0.69 ± 0.45, and CS improved from 0.45 ± 0.41 to 0.79 ± 0.29; mean central macular thickness (CMT) decreased from 515.35 ± 202.83 to 358.35 ± 135.4µ at 12 weeks. All the values were statistically significant (p value < 0.001).

Conclusion

IVTA injection in acute retinal vein occlusion with macular oedema results in electrophysiological (pattern ERG) improvement in addition to anatomical (OCT) improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98:133–141

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Rath EZ, Frank RN, Shin DH (1992) Risk factors for retinal vein occlusion. A case–control study. Ophthalmology 99:509–514

    Article  CAS  PubMed  Google Scholar 

  3. Pe’er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E (1998) Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105(3):412–416

    Article  PubMed  Google Scholar 

  4. Nauck M, Karakiulakis G, PerruchoudAP Papakonstantinou E, Roth M (1998) Corticosteriods inhibit the expression of the vascular endothelial growth factor gene inhuman vascular smooth muscle cells. Eur J Pharmacol 341:309–315

    Article  CAS  PubMed  Google Scholar 

  5. Lee HB, Pulido JS, McCannel CA, Buettner H (2007) Role of inflammation in retinal vein occlusion. Can J Ophthalmol 42(1):131–133

    Article  PubMed  Google Scholar 

  6. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86(2):247–248

    Article  PubMed  PubMed Central  Google Scholar 

  7. Holopigian K, Hood DC (2003) Electrophysiology. Ophthalmol Clin N Am 16:237–251

    Article  Google Scholar 

  8. Gündüz K, Zengin N, Okudan S, Okka M, Ozbayrak N (1995-1996) Pattern-reversal electroretinograms and visual evoked potentials in branch retinal vein occlusion. Doc Ophthalmol 91(2):155–164

  9. Holder GE (1985) Pattern ERG abnormalities in anterior visual pathway disease. Electroenceph Clin Neurophysiol 61(3):S135

    Article  Google Scholar 

  10. Topčić IG, Šuštar M, Brecelj J, Hawlina M, Mekjavić PJ (2014) Morphological and electrophysiological outcome in prospective intravitreal bevacizumab treatment of macular edema secondary to central retinal vein occlusion. Doc Ophthalmol 129(1):27–38

    Article  Google Scholar 

  11. Ogreden TA, Alkin Z, Ozkaya A, Demirkale HI, Perente I, Aras C (2013) Evaluation of contrast sensitivity after single intravitreal triamcinolone injection for macular edema secondary to branch retinal vein occlusion. ISRN Ophthalmol. doi:10.1155/549240

    Google Scholar 

  12. Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK et al (2007) Clinical, anatomic and electrophysiologic evaluation following intravitreal bevacizumab for macular oedema in retinal vein occlusion. Am J Ophthalmol 143:604–606

    Article  Google Scholar 

  13. Kim JY, Park SP (2009) Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol 23:259–265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Krepler K, Ergun E, Sacu S, Richter-Müksch S, Wagner J, Stur M, Wedrich A (2005) Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Acta Ophthalmol Scand 83:600–604

    Article  PubMed  Google Scholar 

  15. Viswanathan S, Frishman LJ, Robson JG (2000) The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci 41:2797–2810

    CAS  PubMed  Google Scholar 

  16. Shetty R, Pai SA, Vincent A, Shetty N, Narayana KM, Sinha B et al (2008) Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular oedema. Doc Ophthalmol 116:129–135

    Article  PubMed  Google Scholar 

  17. Moon CH, Ahn S, Ohn Y-H II et al (2013) Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment. Doc Ophthalmol 126:211–219

    Article  PubMed  Google Scholar 

  18. Moschos MM, Brouzas D, Loukianou E, Apostolopoulos M, Moschos M (2007) Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study. Doc Ophthalmol 114:1–7

    Article  PubMed  Google Scholar 

  19. Morrell AJ, Thompson DA, Gibson JM, Kritzinger EE, Drasdo N (1991) Electroretinography as a prognostic indicator of neovascularisation in CRVO. Eye 5:362–368

    Article  PubMed  Google Scholar 

  20. Johnson MA, Marcus S, Elman MJ, McPhee TJ (1988) Neovascularization in central retinal vein occlusion: electroretinographic findings. Arch Ophthalmol 106:348–352

    Article  CAS  PubMed  Google Scholar 

  21. Noma H, Funatsu H, Harino S, Sugawara T, Mimura T, Shimada K (2011) Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema. Doc Ophthalmolo 123:83–91

    Article  Google Scholar 

  22. Sonmez K, Ozturk F (2012) Complications of intravitreal triamcinolone acetonide for macular oedema and predictive factors for intraocular pressure elevation. Int J Ophthalmol 5:719–725

    PubMed  PubMed Central  Google Scholar 

  23. Rhee DJ, Peck RE, Belmont J, Martidis A, Liu M, Chang J, Fontanarosa J, Moster MR (2006) Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 90:999–1003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pooja Jain.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Statement of human rights

The study was performed in accordance with Universal Declaration of Human Rights.

Statement on the welfare of animals

This article does not contain any studies with animals performed by any of the authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 128 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goyal, J., Agarwal, R., Arora, R. et al. Evaluation of pattern electroretinogram in retinal vein occlusion treated with intravitreal triamcinolone acetonide. Doc Ophthalmol 132, 167–175 (2016). https://doi.org/10.1007/s10633-016-9536-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10633-016-9536-z

Keywords

Navigation